2020
DOI: 10.1253/circj.cj-20-0344
|View full text |Cite
|
Sign up to set email alerts
|

High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases

Abstract: CTRCD is one of the most serious complications, with increased morbidity and mortality. 1,2 Various chemotherapy options, including anthracyclines, alkylating agents, antimetabolites, microtubule inhibitors, monoclonal antibodies, tyrosine kinase inhibitors, and proteasome inhibitors, are R ecent advances in chemotherapy treatment have significantly improved the survival of patients with hematological diseases. As survival rates increase, concerns about chemotherapy-related cardiac dysfunction (CTRCD) have bec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…Chemotherapy-related cardiac dysfunction is now also emerging as being potentially associated with excessive trabeculation. 93 , 94 The phenotype has been interpreted as a myocardial response to drug toxicity, but it may also be a consequence, rather than the cause, of the cardiac dysfunction.…”
Section: Determinants and Associations Of Excessive Trabeculationmentioning
confidence: 99%
“…Chemotherapy-related cardiac dysfunction is now also emerging as being potentially associated with excessive trabeculation. 93 , 94 The phenotype has been interpreted as a myocardial response to drug toxicity, but it may also be a consequence, rather than the cause, of the cardiac dysfunction.…”
Section: Determinants and Associations Of Excessive Trabeculationmentioning
confidence: 99%